Davis's Drug Guide
Tri–Legest Fe
Phase I
norethindrone 1 mg + ethinyl estradiol 20 mcg
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Tri–Legest Fe." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109814/3/Tri–Legest_Fe.
Vallerand AHA, Sanoski CAC. Tri–Legest Fe. Davis's Drug Guide. F.A. Davis Company; 2026. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109814/3/Tri–Legest_Fe. Accessed July 4, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Tri–Legest Fe. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109814/3/Tri–Legest_Fe
Vallerand AHA, Sanoski CAC. Tri–Legest Fe [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 July 04]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109814/3/Tri–Legest_Fe.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tri–Legest Fe
ID - 109814
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109814/3/Tri–Legest_Fe
PB - F.A. Davis Company
ET - 20
DB - Nursing Central
DP - Unbound Medicine
ER -
